Histiocytosis, Sinus: Clinical Trials

4 trials for Histiocytosis, Sinus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 unknown. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 3, Unknown 1

Follow Histiocytosis, Sinus: new trials by email Literature Review of Histiocytosis, Sinus trials Research Report on Histiocytosis, Sinus

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
Lenalidomide, Dexamethasone - Rosai-Dorfman Disease
Phase 2RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences402025-04-122025-09-22
Mirdametinib in Histiocytic Disorders
Mirdametinib - Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG)
Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati402024-02-052026-09-21
Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
lenalidomide and dexamethasone - Rosai-Dorfman Disease
Phase 2UnknownPeking Union Medical College Hospital162021-06-082021-06-16
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Cobimetinib - Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2RecruitingCarl Allen902021-04-192026-10-26

Narrower conditions

Histiocytosis, Langerhans-Cell (2)  ·  Xanthogranuloma, Juvenile (2)  ·  Erdheim-Chester Disease (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytic Sarcoma (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Histiocytosis (4)  ·  Histiocytosis, Non-Langerhans-Cell (4)  ·  Lymphatic Diseases (4)  ·  Lung Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Respiratory Tract Diseases (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Dexamethasone (2)  ·  Lenalidomide (2)  ·  cobimetinib (1)  ·  mirdametinib (1)

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Carl Allen (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Peking Union Medical College Hospital (1)

Countries

China (2)  ·  United States (2)

Top investigators

Allison Bartlett, MD (1)  ·  Ashish Kumar, MD, PhD (1)  ·  Carl E Allen, MD, PhD (1)  ·  Dao-bin Zhou (1)  ·  Xinxin XX Cao, doctor (1)

Results publications

PMID 39022796